focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 488.00
Bid: 471.00
Ask: 491.00
Change: 12.00 (2.52%)
Spread: 20.00 (4.246%)
Open: 478.00
High: 488.00
Low: 474.00
Prev. Close: 476.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Jun 2018 16:45

RNS Number : 1724R
Zotefoams PLC
12 June 2018
 

 

 

Zotefoams plc

(the 'Company')

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs

On 11 June 2018 the Company received notification from the Share Incentive Plan ('SIP') Trustee (Yorkshire Building Society) that on 11 June 2018 the following Directors became beneficially interested in the number of ordinary shares of 5 pence in the Company under the Zotefoams Share Incentive Plan as detailed below. The shares were purchased at a price of £5.7175 per share.

 

The table sets out the number of shares purchased and the number of matching shares that were allocated for nil consideration.

 

Director

Number of partnership shares purchased

No. of matching shares allocated

 

Aggregate number of shares held¹

D B Stirling

26

7

446,219

G C McGrath

26

7

5,045

 

¹ Includes partnership shares, dividend shares and vested matching shares.

 

 

The Notification of Dealing Form for each Director can be found below.

 

This notification is made in accordance with the Market Abuse Regulation.

 

 

Alex Small

Company Secretary

Zotefoams plc

020 8664 1600

 

12 June 2018

 

 

 

About Zotefoams plc:

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).

www.zotefoams.com

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

 

 

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Stirling

2.

Reason for the notification

a)

Position/status: Group CEO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Award of matching shares under the share incentive plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£0.00

7

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£0.00

7

£0.00

e)

Date of the transaction: 11 June 2018

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Purchase of partnership shares under the share incentive plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.7175

26

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£5.7175

26

£148.66

e)

Date of the transaction: 11 June 2018

f)

Place of the transaction: XLON

 

 

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Gary McGrath

2.

Reason for the notification

a)

Position/status: Group CFO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Award of matching shares under the share incentive plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£0.00

7

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£0.00

7

£0.00

e)

Date of the transaction: 11 June 2018

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Purchase of partnership shares under the share incentive plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.7175

26

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£5.7175

26

£148.66

e)

Date of the transaction: 11 June 2018

f)

Place of the transaction: XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEASKAFLLPEFF
Date   Source Headline
18th Mar 20147:00 amRNSFinal Results
15th Jan 20147:00 amRNSTrading Update
19th Nov 20134:19 pmRNSHolding(s) in Company
23rd Oct 20137:00 amRNSTrading Update and Interim Management Statement
17th Oct 20131:21 pmRNSHolding(s) in Company
1st Oct 20132:13 pmRNSDirector Declaration
21st Aug 201312:15 pmRNSDirector/PDMR Shareholding
15th Aug 201312:26 pmRNSDirector/PDMR Shareholding
6th Aug 20137:00 amRNSHalf Yearly Report
12th Jul 20139:29 amRNSJoint Venture in Asia
8th Jul 20137:00 amRNSTrading Update
3rd Jun 201311:37 amRNSDirector/PDMR Shareholding
21st May 20139:43 amRNSDirector/PDMR Shareholding
15th May 201312:02 pmRNSResult of AGM
15th May 20137:00 amRNSAGM Statement and Interim Management Statement
29th Apr 20134:27 pmRNSDirector/PDMR Shareholding
10th Apr 20135:45 pmRNS2012 Annual Report and Accounts and AGM Notice
10th Apr 20132:22 pmRNSHolding(s) in Company (Replacement)
26th Mar 20131:01 pmRNSHolding(s) in Company
19th Mar 20135:43 pmRNSDirector/PDMR Shareholding
19th Mar 20135:40 pmRNSDirector/PDMR Shareholding
15th Mar 201310:00 amRNSHolding(s) in Company
12th Mar 20139:19 amRNSDirector/PDMR Shareholding
5th Mar 20137:00 amRNSFinal Results
18th Feb 20133:14 pmRNSChange of Advisers
9th Jan 20137:00 amRNSTrading Update
14th Nov 20129:56 amRNSDirector Declaration
26th Oct 20127:00 amRNSInterim Management Statement
14th Aug 201211:58 amRNSNotification of Major Interest in shares
14th Aug 20127:00 amRNSMuCell Extrusion LLC Obtains an Exclusive License
7th Aug 20127:02 amRNSHalf Yearly Report
7th Aug 20127:00 amRNSDow and MuCell Extrusion LLC Enter Agreement
9th Jul 20127:00 amRNSTrading Update
12th Jun 201212:15 pmRNSDirector/PDMR Shareholding
10th May 201212:08 pmRNSResult of AGM
10th May 20127:00 amRNSAGM and Interim Management Statement
13th Apr 201212:31 pmRNSHolding(s) in Company
13th Apr 201210:43 amRNSDirector/PDMR Shareholding
5th Apr 20123:25 pmRNSAnnual Information Update
5th Apr 201212:23 pmRNS2011 Annual Report & Accounts and Notice of AGM
5th Apr 201210:31 amRNSDirector/PDMR Shareholding
28th Mar 20128:43 amRNSHolding(s) in Company
6th Mar 20127:00 amRNSFinal Results
27th Jan 201210:57 amRNSHolding(s) in Company
19th Jan 20124:48 pmRNSHolding(s) in Company
9th Jan 20127:00 amRNSTrading Statement
13th Dec 20113:27 pmRNSDirector/PDMR Shareholding
22nd Nov 20117:00 amRNSDirector/PDMR Shareholding
28th Oct 20112:18 pmRNSHolding(s) in Company
24th Oct 20117:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.